Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System

被引:0
|
作者
Ku, Jennifer H. [1 ]
Fischer, Heidi [1 ]
Qian, Lei X. [1 ]
Li, Kris [1 ]
Skarbinski, Jacek [2 ]
Shaw, Sally [1 ]
Bruxvoort, Katia J. [1 ,3 ]
Lewin, Bruno J. [1 ]
Spence, Brigitte C. [1 ]
Tartof, Sara Y. [1 ,4 ]
机构
[1] Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Los Robles,2nd Floor, Pasadena, CA 91101 USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[3] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[4] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA
基金
美国国家卫生研究院;
关键词
latent tuberculosis infection; latent tuberculosis screening; gamma interferon release assay; tuberculin skin test; UNITED-STATES; DIAGNOSIS; DISEASE; ADULTS;
D O I
10.1093/cid/ciae015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Tuberculosis (TB) is a public health threat, with >80% of active TB in the United States occurring due to reactivation of latent TB infection (LTBI). We may be underscreening those with high risk for LTBI and overtesting those at lower risk. A better understanding of gaps in current LTBI testing practices in relation to LTBI test positivity is needed. Methods. This study, conducted between 1 January 2008 and 31 December 2019 at Kaiser Permanente Southern California, included individuals aged >= 18 years without a history of active TB. We examined factors associated with LTBI testing and LTBI positivity. Results. Among 3 816 884 adults (52% female, 37% White, 37% Hispanic, mean age 43.5 years [standard deviation, 16.1]), 706 367 (19%) were tested for LTBI, among whom 60 393 (9%) had >= 1 positive result. Among 1 211 971 individuals who met >= 1 screening criteria for LTBI, 210 025 (17%) were tested for LTBI. Factors associated with higher adjusted odds of testing positive included male sex (1.32; 95% confidence interval, 1.30-1.35), Asian/Pacific Islander (2.78, 2.68-2.88), current smoking (1.24, 1.20-1.28), diabetes (1.13, 1.09-1.16), hepatitis B (1.45, 1.34-1.57), hepatitis C (1.54, 1.44-1.66), and birth in a country with an elevated TB rate (3.40, 3.31-3.49). Despite being risk factors for testing positive for LTBI, none of these factors were associated with higher odds of LTBI testing. Conclusions. Current LTBI testing practices may be missing individuals at high risk of LTBI. Additional work is needed to refine and implement screening guidelines that appropriately target testing for those at highest risk for LTBI.
引用
收藏
页码:1304 / 1312
页数:9
相关论文
共 50 条
  • [41] Identifying Priorities for Testing and Treatment of Latent Tuberculosis Infection in the United States
    Martinez, Leonardo
    Andrews, Jason R.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3483 - E3485
  • [42] Cost-effectiveness of testing for latent tuberculosis infection in people with HIV
    Auguste, Peter E.
    Mistry, Hema
    McCarthy, Noel D.
    Sutcliffe, Paul A.
    Clarke, Aileen E.
    AIDS, 2022, 36 (01) : 1 - 9
  • [43] Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review
    Roth, P. J.
    Grim, S. A.
    Gallitano, S.
    Adams, W.
    Clark, N. M.
    Layden, J. E.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (01) : 14 - 21
  • [44] Treatment of latent tuberculosis infection among healthcare workers at a tertiary hospital in Korea
    Lee, Eun Hye
    Park, Ji Eun
    Shin, Mi Hwa
    Lee, Sang Hoon
    Leem, Ah Young
    Kim, Song Yee
    Jung, Ji Ye
    Park, Moo Suk
    Kim, Young Sam
    Chang, Joon
    Kang, Young Ae
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] USE OF THE TUBERCULIN SKIN TEST TO SCREEN HEALTHCARE WORKERS FOR LATENT TUBERCULOSIS INFECTION
    Plumb, I. D.
    Miller, P.
    Tamne, S.
    Creer, D.
    THORAX, 2008, 63 : A112 - A112
  • [46] Is testing for latent tuberculosis infection in an UK HIV clinic cost effective?
    Capocci, S.
    Smith, C.
    Morris, S.
    Bhagani, S.
    Cropley, I.
    Johnson, M.
    Lipman, M.
    HIV MEDICINE, 2012, 13 : 44 - 44
  • [47] Screening and testing for latent tuberculosis infection among patients who are immunocompromised
    Sierra, Carmen Josefa
    Downs, Charles A.
    NURSE PRACTITIONER, 2022, 47 (11): : 32 - 39
  • [48] Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013
    Marks, Suzanne M.
    Woodruff, Rachel Yelk
    Owusu-Edusei, Kwame
    Asay, Garrett R. Beeler
    Hill, Andrew N.
    PUBLIC HEALTH REPORTS, 2019, 134 (05) : 522 - 527
  • [49] Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco
    Sabri, Ayoub
    Quistrebert, Jocelyn
    Amrani, Hicham Naji
    Abid, Ahmed
    Zegmout, Adil
    Ghorfi, Ismail Abderrhamani
    Souhi, Hicham
    Boucaid, Abdelhalim
    Benali, Anas
    Abilkassem, Rachid
    Kmari, Mohamed
    Hassani, Amal
    Lahcen, Belyamani
    Siah, Samir
    Schurr, Erwin
    Boisson-Dupuis, Stephanie
    Casanova, Jean-Laurent
    Lahlou, Amine
    Laatiris, Abdelkader
    Louzi, Lhoussain
    Ouarssani, Aziz
    Bourazza, Ahmed
    Aouragh, Aziz
    Mustapha, Bensghir
    Messaoudi, Nezha
    Agader, Aomar
    Cobat, Aurelie
    Abel, Laurent
    El Baghdadi, Jamila
    PLOS ONE, 2019, 14 (08):
  • [50] The Need for Performance Measures on Testing for Latent Tuberculosis Infection in Primary Care
    Tschampl, Cynthia
    Bernardo, John
    Garvey, Thomas
    Garnick, Deborah
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2011, 37 (07): : 309 - 316